|55 Kenosia Avenue
Danbury, CT 06810
Toll Free: 1.800.999.6673
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
Copyright 1987, 1989, 1996, 1997, 2005, 2009
Leptospirosis is an infectious disease that affects humans and animals. It results in a wide range of symptoms, and some people may have no symptoms at all. It is caused by a spiral-shaped bacterium (spirochete). Symptoms include high fever, chills, muscle aches, headache, vomiting, diarrhea, and jaundice (yellow skin and eyes).
A definitive diagnosis requires laboratory testing of a blood or urine sample. Early detection is important because the disease can cause serious complications if not treated early in its course. These include kidney damage (nephrosis), meningitis (inflammation of the tissue around the brain or spinal cord), respiratory distress and/or liver failure.
The symptoms of leptospirosis vary considerably. Some people may experience no symptoms at all. Some may experience moderate or more severe flu-like symptoms. Some may experience very serious complications if the disease is not treated.
The disorder characteristically occurs in two phases. The septocemic phase starts abruptly with headache, pain behind the eyeball (retroorbital), lack of appetite (anorexia), severe muscle aches, chills, sweating, nausea, vomiting, and fever. Constipation, diarrhea, symptoms of the common cold, coughing, chest pain, a stiff neck, and difficulty breathing (dyspnea) may also occur. Enlargement of the spleen (splenomegaly) and liver (hepatomegaly) are uncommon, but may occur. This phase usually lasts four to nine days, with recurrent chills and fever that spikes to over 39 degrees C (102 F), and then abates.
The sixth to 12th day of illness marks the immune (or second) phase of leptospirosis. Antibodies appear in the blood serum. Fever and earlier symptoms may recur, and symptoms of irritated membranes lining the brain (meninges) may develop. Examination of the cerebrospinal fluid after the seventh day shows a greater than normal number of cells (pleocytosis) in at least 50 percent of patients. Inflammation of the iris and the ciliary body behind the iris (iridocyclitis), the optic nerve (optic neuritis), and peripheral disease of the nerves (neuropathy) may occur infrequently. If acquired during pregnancy, leptospirosis may cause abortion, even during the period of convalescence.
Humans usually become infected through contact with water, food or soil containing urine from infected animals. The bacterium associated with the disease, Leptospira, can be found in the urine of many different animals, such as dogs, cats, cattle, horses, pigs, and, especially, rodents. The disease is transmitted to humans when infected urine enters the body when one swallows contaminated food or water or through breaks in the skin or contact with mucosal surfaces such as the eyes or nose. The disease is not known to be spread from person to person.
The usual period of time between exposure to the bacterium and appearance of the disease is from two to 20 days.
While leptospirosis is rare in the United States, it is common through tropical and semitropical regions. It can affect individuals of all ages. At least 75 percent of individuals with leptospirosis are male, mainly because workers in jobs that are at risk of the infection are more often held by males.
The infection is an occupational disorder affecting farmers, veterinarians, workers in slaughter houses and sewer workers. However, many affected individuals are thought to be exposed incidentally during recreational activities, such as swimming in water contaminated by the urine of infected animals.
In recent years, several cases of leptospirosis have been reported in urban areas, especially inner city neighborhoods. It is thought that these areas are infested with rats that carry the infection.
Many types of bacterial infections may cause fever and other symptoms similar to the symptoms of leptospirosis.
Weil syndrome is a severe form of bacterial infection caused by Leptospira bacteria (Leptospirosis) causing abnormal liver and kidney function. (For more information on this disorder, choose "Weil Syndrome" as your search term in the Rare Disease Database.)
Meningitis is an infection of the membrane lining the skull or the spinal cavity (meninges) by either bacteria or viruses. (For more information on this disorder, choose "Meningitis" as your search term in the Rare Disease Database.)
Diagnosis may be made during the early stage of the infection (days 1-7) by culturing the Leptospira bacterium from body fluids. From days 4 through 10, the cerebrospinal fluid is cultured, and after day 10, the patient's urine may be cultured. There are other tests of the blood and immune system that may be performed.
Leptospirosis is treated with antibiotics such as penicillin, oral doxycycline, streptomycin, chloramphenicol, and erythromycin.
Mechanical ventilation has been used successfully in treating respiratory distress in leptospirosis patients.
Peritoneal dialysis in combination with treatment with antibiotics has been used successfully to treat severe liver and kidney failure in patients with leptospirosis.
The risk of infection may be greatly reduced by not swimming in waters that may be contaminated with animal urine. People who work in jobs where this might be an occupational hazard, should wear appropriate protective clothing to avoid skin contact if possible. Pet-owners should be aware of the possibility of infection of household pets.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
1600 Clifton Road NE
Atlanta, GA 30333
Phone #: 404-639-3534
800 #: 800-232-4636
Home page: http://www.cdc.gov/
PO Box 8126
Gaithersburg, MD 20898-8126
Phone #: 301-251-4925
800 #: 888-205-2311
Home page: http://rarediseases.info.nih.gov/GARD/
NIAID Office of Communications and Government Relations
5601 Fishers Lane, MSC 9806
Bethesda, MD 20892-9806
Phone #: 301-496-5717
800 #: 866-284-4107
Home page: http://www.niaid.nih.gov/
Avenue Appia 20
Geneva 27, 1211 Switzerland
Phone #: 412-279-12111
800 #: --
Home page: http://www.who.int/en/
Ashford DA, Sejvar JJ. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:289.
Tappero JW, Ashford DA, Perkins BA. Leptospirosis. In: Mandell GL, Bennett JE, Dolan R. Eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Churchill Livingstone Inc. New York, NY; 2000:2495-501.
Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Semin Nephrol. 2003;23:42-48.
Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med. 2002;23:469-78.
Vinetz JM. Leptospirosis. Curr Opin Infect Dis. 2001;14:527-38.
Jones S, Kim T. Fulminant leptospirosis in a patient with human immunodeficiency virus infection: case report and review of the literature. Clin Infect Dis. 2001;33:E31-33.
Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother. 2001;7:59-68.
Mahy BW, Brown CC. Emerging zoonoses: crossing the species barrier. Rev Sci Tech. 2000;19:33-40.
Guidugli F, Castro AA, Atallah AN. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev. 2000:CD001305.
FROM THE INTERNET
Leptospirosis. CDC. Division of Bacterial and Mycotic Diseases. Last reviewed March 7, 2003. 3pp
Leptospirosis. Health & Safety Executive. nd. 2pp.
Leptospirosis. New York State Department of Health, Communicable Disease. Revised: March 2003. 2pp.
Leptospirosis. State of Wisconsin, Department of Health & Family Services. Last Revised: July 02, 2001.
Leptospirosis. Association of State and Territorial Directors of Health Promotion and Public Health Education (ASTDHPPHE). Nd. 3pp.
Report last updated: 2009/04/10 00:00:00 GMT+0